Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiahui International Cancer Center (JICC) is a leading oncology facility located within Jiahui International Hospital in Shanghai, China. Established in strategic collaboration with the Massachusetts General Hospital (MGH) Cancer Center, JICC provides international-standard cancer care including screening, diagnosis, and multidisciplinary treatment. The center offers advanced services in medical oncology, surgical oncology, and radiation oncology, utilizing MGH-derived clinical protocols. JICC also serves as a significant site for clinical trials and precision medicine, aiming to bring innovative therapies to patients in the region through a patient-centric, integrated care model.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiahui International Cancer Center.